ResMed develops diagnoses and treatments for sleep apnoea, COPD and other respiratory conditions worldwide.
The healthcare sector has spent much of 2026 going against the expectations associated with it. Healthcare is meant to be the defensive part of the ma...
More than 250 ASX-listed companies are releasing FY26 results across the five weeks from 3 to 31 August, and the tone of...
Get alerts when news about RMD is published